Sustained release intraocular drug delivery devices for treatment of uveitis - Wikidata - awgldk - TriplyDB

Sustained release intraocular drug delivery devices for treatment of uveitis

Sustained release intraocular drug delivery devices for treatment of uveitis

http://www.wikidata.org/entity/Q35835614

about

Substrates for Expansion of Corneal Endothelial Cells towards Bioengineering of Human Corneal Endothelium Current trends in the monitoring and treatment of diabetic retinopathy in young adults Evaluation of a prednisolone acetate-loaded subconjunctival implant for the treatment of recurrent uveitis in a rabbit model Review of Systemic Immunosuppression for Autoimmune Uveitis One-Year Feasibility Study of Replenish MicroPump for Intravitreal Drug Delivery: A Pilot Study.Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation.Investigation of Diffusion Characteristics through Microfluidic Channels for Passive Drug Delivery Applications The future of uveitis treatment JOVR Uveitis Issue; Partnership between European and Middle Eastern Ophthalmologists.New Drugs and New Posterior Delivery Methods in CME.The effects of repeated Ozurdex injections on ocular hypertension.Intracameral dexamethasone injection in the treatment of cataract surgery induced inflammation: design, development, and place in therapy

P2860

Q26785894-BA09F12D-8480-4CF0-B694-49DFD994E546 Q26863388-BC18E504-E054-451F-AE84-679834D0937D Q33633008-D164051A-2A2A-47F8-9F04-9050C6EA0DDC Q34627012-0A44C101-2EC3-4755-9643-9DE44A4E7641 Q35167647-03989414-EAC7-4EFB-B637-7EB08EE51F4A Q36369061-8843597A-1494-4FBD-A924-73826D6FFF0D Q36985582-2006439E-EC6F-4CEF-AD09-69F919D6DA22 Q37554382-08DEB07B-BBBC-4A91-8546-36592FDC2CF9 Q42135132-DE0789FF-1492-46FC-A04E-BCD8E174998B Q50073381-F90F08D6-0FFE-4E36-BF8F-50EFC52C9C5F Q53829701-BA892537-073D-48EF-AA71-F4DE5F66799A Q59125905-6B5D7731-77C5-4DBC-87D1-DDFF828973B2

P2860

Sustained release intraocular drug delivery devices for treatment of uveitis

http://www.wikidata.org/entity/Q35835614

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Sustained release intraocular drug delivery devices for treatment of uveitis

@ast

Sustained release intraocular drug delivery devices for treatment of uveitis

@en

type

label

Sustained release intraocular drug delivery devices for treatment of uveitis

@ast

Sustained release intraocular drug delivery devices for treatment of uveitis

@en

prefLabel

Sustained release intraocular drug delivery devices for treatment of uveitis

@ast

Sustained release intraocular drug delivery devices for treatment of uveitis

@en

P1433

Q35835614-49C8E575-5C1D-4761-B0BF-7391640D4D73

P1476

Q35835614-E1B407BD-C1D3-4CA9-820C-9EB8A20DD1F8

P2093

Q35835614-3FB5D2E7-0EDE-4D95-A6E7-7D86173413BF

Q35835614-44241106-B58A-4C7B-9661-D6B927C185F8

Q35835614-5CF52C71-DD47-4D16-A824-D9FE608A8586

P2860

Q35835614-024863F7-BDCA-4239-873B-4E462B753E75

Q35835614-0E889DB4-A5AD-4D36-B730-6C07C86FCD61

Q35835614-159B7F79-BADA-4BEF-B5A0-FEF4AF99CE0B

Q35835614-17AF1CA0-F0E6-44B4-A3EC-B958B2EC3A8D

Q35835614-1B4D27C6-4271-4D1D-B2A5-D610FD3C3D0A

Q35835614-1BEA5864-6C74-4104-823E-55268C70D5C2

Q35835614-1D10FDED-9CEF-4D65-8484-3EB3BB3226BD

Q35835614-2884B2DF-3345-411A-863A-283B22C16B72

Q35835614-344B214C-4F46-4CC5-BC37-146C01E3BC3B

Q35835614-36D4D20D-EAAE-4D6B-A4F5-E927AF7FCB8C

P304

Q35835614-625AF06F-7983-4EBB-9023-F7E8AC03579A

P31

Q35835614-2FFA3BAF-E00C-4694-86E8-5E4F1A0A1DD2

P433

Q35835614-DF8E5784-0C1A-4E2A-8EDE-807E51A25FD1

P478

Q35835614-90869CE4-6B51-43D2-9483-4A182F9B0A28

P577

Q35835614-174561E1-0469-40A2-9CF5-A6529CDB9DE4

P698

Q35835614-E059AD35-0057-4343-9A99-918746FC3930

P921

Q35835614-527A8DD6-BC6A-4CD4-8D4D-3934D91DE308

Q35835614-67BEA018-1654-44FE-AE14-A6C73C66883F

P932

Q35835614-E4B30766-BC6A-4A71-8C37-E598571ED017

P1433

Journal of Ophthalmic & Vision Research

P1476

Sustained release intraocular drug delivery devices for treatment of uveitis

@en

P2093

Masoud Soheilian

http://www.w3.org/2001/XMLSchema#string

Mohammad Jafar Abdekhodaie

http://www.w3.org/2001/XMLSchema#string

Nahid Haghjou

http://www.w3.org/2001/XMLSchema#string

P2860

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery: anterior versus posterior placement of two Surodex in the eye.

Ocular penetration of cyclosporin A. III: The human eye

New and emerging treatments for patients with uveitis.

Colloidal carriers for ophthalmic drug delivery.

Retisert: is the new advance in treatment of uveitis a good one?

Current and future ophthalmic drug delivery systems. A shift to the posterior segment.

Recent perspectives in ocular drug delivery.

Causes and frequency of blindness in patients with intraocular inflammatory disease.

The possible impact of uveitis in blindness: a literature survey.

P304

317-329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22454753

http://www.w3.org/2001/XMLSchema#string

P921

P932

3306122

http://www.w3.org/2001/XMLSchema#string